decade Candida infections, especially candidemia, due to C. albicans have declined [ 6 ] . Other non-C. albicans Candida species (NAC) are now responsible for about half of the candidemias and other Candida infections [ 7 ,8 ] . Most NAC infections are caused by C . glabrata, C. parapsilosis, C. krusei or C. tropicalis , although in total over a dozen NAC have been reported to cause candidemia and other invasive infections [ 9 -11 ] . AMB, FLU and caspofungin are currently the three antifungal agents most commonly used to treat candidemia and invasive candidiasis. However in vitro testing has revealed that there are clear differences among the various NAC in their susceptibility to drugs. The needed long term suppressive therapy with antifungal agents for these infections is widely used, but some of them have been reported as ineffective and even toxic to the host [ 12 ] . Most patients who experience clinical failure with FLU will have Candida species isolates that show in vitro resistance to the antifungal [ 13, 14 ] . In 1997, the NCCLS Subcommittee for Antifungal Susceptibility Testing proposed tentative breakpoints for antifungal
Introduction
Trichosporon spp. is the causative agents of white piedra, superfi cial infections and invasive trichosporonosis and has emerged as an opportunistic fungal pathogen [ 1, 2 ] . Trichosporonosis, the deep-seated infection caused by this fungus, is an often fatal disease affecting mostly immunocompromised hosts [ 3, 4 ] . Treatment of this infection with the currently available antifungal agents has generally been unrewarding, and clinical failures with amphotericin B (AMB), fl uconazole (FLU), and the combination of the two have been reported [ 1 ,3, 5 ] . Candida albicans once accounted for the most serious nosocomial candidal infections. Over the last agents active against Candida species, and these breakpoints were subsequently approved [ 15 ] . Isolates with a FLU MIC Ͻ 8 μg/ml are classifi ed as sensitive, those with 8-32 μg/ml as dose-dependent sensitive, and those with an MIC Ն 64 μg/ml resistant [ 15 ] .
Therefore the search for new antifungal agents is necessary and stimulates research on new chemotherapeutic agents in natural products. Honey has been used since ancient times for the treatment of several diseases. The antibacterial activity of honey was reviewed by Molan [ 16 ] .The high osmolarity and acidity of honey is among the physical characteristics that contribute to its antimicrobial activity. Furthermore hydrogen peroxide and phytochemical components are important factors that provide the antimicrobial activity of honey [ 16 ] . Although numerous in vitro studies have demonstrated the antibacterial activity of honey [ 17 -19 ] , limited number of investigations have examined the activity of honey against fungi. Sissons et al . [ 20 ] reported that Manuka honey may be of benefi t in oral infections where C. albicans is prominent. In a recent study, Boukraa et al. [ 21 ] found that the MIC of fi ve varieties of honey against C. albicans ranged between 40% and 50% (v/v). According to , the minimum concentration of honey in nutrient agar media required to inhibit C. albicans was 66% (v/v). Irish et al . [ 23 ] also reported that honey has signifi cant antifungal activity against clinical isolates of C. albicans , C. glabrata and C. dubliniensis . The current study was carried out to assess the in vitro antifungal activity of four Turkish honey samples from different botanical origin against Trichosporon spp. and Candida spp., as well as to determine the activity against FLU-resistant strains with the CLSI M27-A2 method.
Materials and methods

Honey samples
Four honey varieties from different botanical origins were used; rhododendron ( Rhododendron ponticum L.) from Rize (Black Sea Region), eucalyptus ( Eucalyptus camaldulensis ) and orange trees ( Citrus spp.) from Mersin (South Anatolia) and multifl oral ( Thymus spp., Astragalus spp., Brassica spp.) from Erzurum (East Anatolia) which were collected directly from professional beekeepers in Turkey. The extraction of honeys from combs was obtained by centrifugation. The preparation of honey samples for identifi cation of botanical origin followed the standardized method of Louveaux [ 24] : 10 g of well homogenized honey was dissolved in 20 ml of distilled water and centrifuged for 10 min at 1,350 g at ca. 2,500 rpm [ 25 ] . The decanted sediment was washed with 5-10 ml of distilled water. After another centrifugation, the sediment was resuspended in 5 ml of 1:1 glycerin:distilled water mixture and then centrifuged again, decanted, and mounted with glycerin jelly on microscope slides which were sealed with paraffi n. The pollen types present in the honey samples were identifi ed, counted, and classifi ed, according to their percentages, as dominant pollen (more than 45% of the total pollen grains counted), secondary pollen (from 16-45%), important minor pollen (from 3-15%), and minor pollen (less than 3%). Counts were expressed as percentages after counting a minimum 1,000 pollen grains on four slides from sample.
Yeast strains and susceptibility testing
Forty strains were isolated from blood, sputum, transtracheal aspirates (TTA), urine, branchalveolar lavage (BAL), and nail specimens in the Microbiology and Clinical Microbiology Department of Gevher Nesibe Hospital of Erciyes University. Isolates were collected over a 6-month period in the Mycology Laboratory. They included ten strains of C. glabrata , nine strains of C. albicans , eight strains of C. krusei and thirteen strains of Trichosporon spp. The isolates were identifi ed using standard methods and the API 20C AUX (bioMerieux SA, France) [ 26 ] , and stored Ϫ20°C in tryptic soy broth containing 10% glycerin until used in the study. Prior to use, the yeast were thawed and subcultured at least twice on Sabouraud glucose agar plates. For quality control C. albicans ATCC 90028 was also included in the experiments. FLU (Fako Co. Istanbul, Turkey) was obtained from the manufacturers as defi ned powders. The Clinical and Laboratory Standards Institute (CLSI, M27-A2) microdilution broth method was used to determine the MICs [ 27 ] . Stocks and dilutions of honeys and FLU were prepared in sterile distilled water. Final drug concentrations in the microdilution plates ranged from 64-0.125 μg/ml for FLU and from 80-1.25% (v/v) for all of the honeys. The microdilution plates were prepared by using the synthetic medium RPMI 1640 broth medium (Sigma Chemical Company, Madrid, Spain) with l-glutamine but without sodium bicarbonate and buffered at pH 7.0 with 0.165 mol/l of morpholinepropansulfonic acid (MOPS) (Sigma Chemical Company). Yeast suspensions for spectrofotometric measurements were prepared after vortexing and adjusting to a 0.5 Mc Farland standard transmittance at a wavelength of 530 nm for Trichosporon spp. after serial dilution of the above described suspensions. The fi nal inoculum yielded was of 0.5 ϫ 10 3 -2.5 ϫ 10 3 cells/ml, which was confi rmed by performing colony counts on SDA plates. MICs were visually determined at 24 h of incubation at 35 o C, and were observed for the presence or absence of growth. Each isolate was tested in duplicate and the assays were repeated on a separate day.
Statistical analysis
MIC values (%) were transformed base on Arc sin √Y due to the fact that data do not have normality assumptions. Two-way ANOVA was not performed because of heteroscedasticity. Therefore, Friedman test, a nonparametric test, was performed to test whether there were any differences among the treatments of strains and honeys for MIC values. Then, Dunn's multiple comparison tests were applied to determine any further differences among the groups. All the computational work was performed by means of MINITAB (Minitab V. 13.20, 2000) [ 28 ].
Results
The broth microdilution assay enabled screening of honey samples from different botanical sources to assess the inhibition of growth of Candida spp. and Trichosporon spp. The in vitro activity of honey samples and FLU against four species of Candida spp. and Trichosporon spp. represented by 40 yeast strains are shown in (μg/ml) FLU microorganisms. Although the differences was low, the order of activity in terms of overall activity against all; multifl oral Ͼ rhododendron Ͼ eucalyptus Ͼ orange. It was found that three Candida spp. strains ( C. glabrata 2, C. krusei 1), and one of Trichosporon spp. failed to respond to FLU ( Table 3 ). In the present study 23 of 40 isolates for which MICs were Ͻ 8 μg/ml and 13 were dose-dependent strains but 4 of 40 isolates were resistant strains to FLU. MIC ranges of honey samples were between 40-80% (v/v) against FLU resistant strains.
Discussion
This study demonstrates the in vitro antifungal activity of locally obtained unprocessed honey samples against Candida spp. and Trichosporon spp. All honey samples analyzed had antifungal activity which is seen at concentrations as low as 1.25% (v/v); however the greatest Table 1 . When the antifungal activity of honeys tested was compared, statistically signifi cant differences were determined among the honeys ( P Ͻ 0.05). Multi-fl oral honey was signifi cantly more active against the three Candida species and Trichosporon spp. ( P Ͻ 0.05) than the other honey samples tested ( Table 2 ). The orange honey exhibited lowest antifungal activity against the yeasts tested ( P Ͻ 0.05). The inhibition effect considerably decreased when honey samples were diluted from 40-20% (v/v) . In general multi fl oral and rhododendron honeys showed stronger inhibition of the growth of fungi tested than eucalyptus and orange honeys. Trichosporon spp. was the more susceptible than Candida spp. ( P Ͻ 0.05) and C. albicans was the least susceptible of the Candida species tested ( P Ͻ 0.05).
The results revealed remarkable variations in antifungal activity of the tested honey samples. All of the honey samples had antifungal activity against the tested Different superscript letters (a, b and c) within same line showed signifi cant (P Ͻ 0.05) differences among the group. could be incorporated in the therapy of oral and vaginal candidiasis. The fungal infections have emerged as a major cause of disease and mortality, in part as a consequence of the increase in acquired immunodefi ciency syndrome, the long term use of corticosteroids, and even the use of indiscriminate antifungals. Therefore, toxicity concerns, limited spectrum, and the emergence of fungi resistant to currently available agents have created a need for antifungal agents and in particular antifungal agents effective against systemic mycoses caused by Candida species. This result allows researchers to adopt different therapeutic options with a large number of species of superfi cial mycoses and with a high probability of successful results.
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Honey has a potent antimicrobial activity and is very effective in cleaning infected wounds and protecting them from becoming infected [ 35 ] . According to Irish et al . [ 23 ] , honey is limited to topical treatments, and could not be used to treat candidemia, the most serious form of candidiasis. However skin fungal infections contributed to the use of topical preparations that contain antifungal ingredients including fl avonoids or antioxidants. Honey may be used to prevent more serious infections and
